Literature DB >> 6187672

Monoclonal antibodies to influenza A virus FM1 (H1N1) proteins require individual conditions for optimal reactivity in binding assays.

K Kammer.   

Abstract

The physical environments for optimal display of individual antigenic determinant sites on influenza A/FM/1/47 virus, with preference of its haemagglutinin, were established with monoclonal antibodies based on an enzyme-linked binding assay (ELISA). Comparisons were made with requirements of serum-derived antibodies to form immune complexes. Two-coating buffers revealed profound differences in their inherent capacities to provide antigenic reactivity; this activity became further altered when, after adsorption, the antigens were briefly exposed to either methanol or formaldehyde. Ionic strength started to become restrictive on formation of immune complexes above 0.2 M NaC1. The binding of the monoclonal antibodies to the haemagglutinin was charge-dependent. The form of its presentation, located on the viral surface or as an isolated component, further modified the pH-requirements for its optimal display in antigenic reactivity. The binding of serum-derived antibodies differed markedly and showed a dependence neither on the charge nor on the structural form of the haemagglutinin. Pretreatment of the haemagglutinin on the viral surface with small concentrations (0.025-0.05%) of Triton X-100, sodium dodecyl sulphate (SDS) and cetyltrimethyl ammonium bromide (CTAB), strongly changes the accessibility of its determinant sites, while deoxycholate (DOC) and octyl-beta-D-glucoside (OG) were not effective at the same concentrations. None of these detergents, however, altered the binding properties of the isolated component. Instead, some of them even improved its capacity to form immune complexes.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6187672      PMCID: PMC1454057     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  26 in total

1.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

2.  An immunological approach to the conformational equilibrium of staphylococcal nuclease.

Authors:  B Furie; A N Schechter; D H Sachs; C B Anfinsen
Journal:  J Mol Biol       Date:  1975-03-15       Impact factor: 5.469

3.  Selective solubilization of hemagglutinin and neuraminidase from influenza viruses.

Authors:  H Bachmayer
Journal:  Intervirology       Date:  1975       Impact factor: 1.763

4.  Enzyme-linked immunosorbent assay, Elisa. 3. Quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes.

Authors:  E Engvall; P Perlmann
Journal:  J Immunol       Date:  1972-07       Impact factor: 5.422

5.  Studies on the origin of pandemic influenza. I. Antigenic analysis of A 2 influenza viruses isolated before and after the appearance of Hong Kong influenza using antisera to the isolated hemagglutinin subunits.

Authors:  R G Webster; W G Laver
Journal:  Virology       Date:  1972-05       Impact factor: 3.616

6.  Characterization of the ribonucleoprotein and neuraminidase of influenza A viruses by immunodiffusion.

Authors:  G C Schild; H G Pereira
Journal:  J Gen Virol       Date:  1969-04       Impact factor: 3.891

7.  Binding of antibodies to isolated haemagglutinin and neuraminidase molecules of influenza virus observed in the electron microscope.

Authors:  N G Wrigley; W G Laver; J C Downie
Journal:  J Mol Biol       Date:  1977-01-25       Impact factor: 5.469

8.  Host defenses against influenza virus: the role of anti-hemagglutinin antibody.

Authors:  J L Virelizier
Journal:  J Immunol       Date:  1975-08       Impact factor: 5.422

9.  Monoclonal antibodies against rabies virus produced by somatic cell hybridization: detection of antigenic variants.

Authors:  T J Wiktor; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

10.  The analysis of the monoclonal immune response to influenza virus. II. The antigenicity of the viral hemagglutinin.

Authors:  W Gerhard
Journal:  J Exp Med       Date:  1976-10-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.